For our sixth episode of the GHAPP & RhAPP biosimilar podcast series host Gabriella McCarty, NP-C, and guest Janette Villalon, NP discuss interchangeability & switching of biosimilars.
The learning objectives and goals for this episode are to:
-Define interchangeability
-Illustrate the required info for a biosimilar to be deemed interchangeable by the FDA
-Recognize how interchangeability studies are conducted
-Analyze what interchangeability and switching mean for:
-APPs
-Pharmacists
-Patients
Please take our evaluation regarding this podcast here: https://www.ghapp.org/biosimilars-podcast-eval
